Alantolactone enhances the sensitivity of melanoma to MAPK pathway inhibitors by targeting inhibition of STAT3 activation and down-regulating stem cell markers
2024 · Cancer Cell International · 7 citations
https://doi.org/10.1186/s12935-024-03371-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
25
Citations
2
h-index
1
i10-index
Kun Zhao is an academic researcher from Beijing University of Posts and Telecommunications. The author has contributed to research in topics: Context-Aware Activity Recognition Systems & Melanoma and MAPK Pathways & Cancer Immunotherapy and Biomarkers. The author has an h-index of 2, co-authored 7 publications.
https://doi.org/10.1186/s12935-024-03371-9
https://doi.org/10.1016/j.cca.2024.120100
Click to start Chat